
Onco-Innovations Announces Private Placement
Onco-Innovations Announces Private Placement

Onco-Innovations Announces Private Placement
Jack Nathan names co-founder Di Cesare as interim CEO
Tempramed Technologies releases VIVI Med
Jack Nathan Medical Corp. Announces CEO Transition and Strategic Investor Alignment
Cardiol closes $14.85-million bought deal financing
Bionxt Solutions to issue six million shares for debt
Bausch Health's RED-C trials fail to meet end point
TempraMed Launches New Product "VIVI Med(TM)," Unlocking New Growth Opportunities in High-Value Biologics and Injectable Medications
Aja Health and Wellness Inc. Announces Agreement Between Assured Diagnosis Inc. and Greatway Financial Inc. and Implementation of New Electronic Medical Records Software for GOeVisit
Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million
Thiogenesis Presents Phase 2 (EU) MELAS Data at Mitocon 2026
Bausch Health Provides Update on RED-C Phase 3 Clinical Trials
LIR Life Sciences Completes Design of Ex Vivo Animal Study to Evaluate Novel Transdermal Agents for Transport of Larger Therapeutic Molecules
ROCKET DOCTOR AI INC. ANNOUNCES CLOSING OF LISTED ISSUER FINANCING EXEMPTION (LIFE) PRIVATE PLACEMENT OF UNITS
FendX and Aquaox Enter into Collaboration Agreement to Pursue Innovation in Eco-Friendly Antimicrobial Agents